- Home
- Publications
- Publication Search
- Publication Details
Title
B cell checkpoints in autoimmune rheumatic diseases
Authors
Keywords
-
Journal
Nature Reviews Rheumatology
Volume 15, Issue 5, Pages 303-315
Publisher
Springer Science and Business Media LLC
Online
2019-04-09
DOI
10.1038/s41584-019-0211-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Indatuximab Ravtansine (BT062) Monotherapy in Patients With Relapsed and/or Refractory Multiple Myeloma
- (2019) Sundar Jagannath et al. Clinical Lymphoma Myeloma & Leukemia
- T Follicular Helper Cell-Germinal Center B Cell Interaction Strength Regulates Entry into Plasma Cell or Recycling Germinal Center Cell Fate
- (2018) Wataru Ise et al. IMMUNITY
- The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in rheumatoid arthritis
- (2018) Yi Tian Ting et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of GDC-0853: A Potent, Selective, and Noncovalent Bruton’s Tyrosine Kinase Inhibitor in Early Clinical Development
- (2018) James J. Crawford et al. JOURNAL OF MEDICINAL CHEMISTRY
- Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
- (2018) Daniel J Wallace et al. LANCET
- Role of Bruton’s tyrosine kinase in B cells and malignancies
- (2018) Simar Pal Singh et al. Molecular Cancer
- Pneumocystis jirovecii pneumonia in HIV-uninfected, rituximab treated non-Hodgkin lymphoma patients
- (2018) Kai-Che Wei et al. Scientific Reports
- T cell-dependent affinity maturation and innate immune pathways differentially drive autoreactive B cell responses in rheumatoid arthritis
- (2018) Daniel R. Lu et al. Arthritis & Rheumatology
- Affinity Maturation Drives Epitope Spreading and Generation of Pro-inflammatory Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis
- (2018) Serra E. Elliott et al. Arthritis & Rheumatology
- Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus
- (2018) Joan T. Merrill et al. Arthritis & Rheumatology
- Brief Report: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis
- (2018) Laurence E. Cheng et al. Arthritis & Rheumatology
- Building blocks for bispecific and trispecific antibodies
- (2018) Xiufeng Wu et al. METHODS
- Regulation of the Germinal Center Response
- (2018) Marisa Stebegg et al. Frontiers in Immunology
- Safety, pharmacokinetics, and pharmacodynamics of BMS-986142, a novel reversible BTK inhibitor, in healthy participants
- (2017) Sun Ku Lee et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Impact of tofacitinib treatment on human B-cells in vitro and in vivo
- (2017) Marta Rizzi et al. JOURNAL OF AUTOIMMUNITY
- B cell–derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity
- (2017) Tanvi Arkatkar et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial
- (2017) Roy Fleischmann et al. LANCET
- Safety and tolerability of inebilizumab (MEDI-551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised, placebo-controlled, escalating intravenous and subcutaneous dose study
- (2017) Mark A Agius et al. Multiple Sclerosis Journal
- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2017) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overexpression of the Cytokine BAFF and Autoimmunity Risk
- (2017) Maristella Steri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis
- (2017) Peter C. Taylor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bruton's tyrosine kinase inhibitor BMS-986142 in experimental models of rheumatoid arthritis enhances efficacy of agents representing clinical standard-of-care
- (2017) Kathleen M. Gillooly et al. PLoS One
- Safety and tolerability of inebilizumab (MEDI-551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised, placebo-controlled, escalating intravenous and subcutaneous dose study
- (2017) Mark A Agius et al. Multiple Sclerosis Journal
- Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials
- (2017) Megan E. B. Clowse et al. Arthritis & Rheumatology
- Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study
- (2017) William Stohl et al. Arthritis & Rheumatology
- Effect of Continuous B Cell Depletion With Rituximab on Pathogenic Autoantibodies and Total IgG Levels in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
- (2017) Frank B. Cortazar et al. Arthritis & Rheumatology
- Peripheral CD19hi B cells exhibit activated phenotype and functionality in promoting IgG and IgM production in human autoimmune diseases
- (2017) Zhicui Liu et al. Scientific Reports
- Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial
- (2016) Daniel J Wallace et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma
- (2016) Saad Z. Usmani et al. BLOOD
- Therapeutic Activity of Agonistic, Human Anti-CD40 Monoclonal Antibodies Requires Selective FcγR Engagement
- (2016) Rony Dahan et al. CANCER CELL
- Targeting B cells in treatment of autoimmunity
- (2016) S Elizabeth Franks et al. CURRENT OPINION IN IMMUNOLOGY
- Baricitinib for the treatment of rheumatoid arthritis
- (2016) Satoshi Kubo et al. Expert Review of Clinical Immunology
- Safety, PK, and PD of recombinant anti-interleukin-21 monoclonal antibody in a first-in-human trial
- (2016) Stanislav Ignatenko et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Autoreactive CD19+CD20−Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis
- (2016) Ding Chen et al. JOURNAL OF IMMUNOLOGY
- Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
- (2016) Dinesh Khanna et al. LANCET
- Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors
- (2016) Daniel F. Ortiz et al. Science Translational Medicine
- B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity
- (2016) Federica Piancone et al. Scientific Reports
- Engagement of CD22 on B cells with the monoclonal antibody epratuzumab stimulates the phosphorylation of upstream inhibitory signals of the B cell receptor
- (2016) Simon Lumb et al. Journal of Cell Communication and Signaling
- A unique population of IgG-expressing plasma cells lacking CD19 is enriched in human bone marrow
- (2015) H. E. Mei et al. BLOOD
- Clinical and Biological Effects of an Agonist Anti-CD40 Antibody: A Cancer Research UK Phase I Study
- (2015) P. Johnson et al. CLINICAL CANCER RESEARCH
- Interleukin 35-Producing B Cells (i35-Breg): A New Mediator of Regulatory B-Cell Functions in CNS Autoimmune Diseases
- (2015) Charles E. Egwuagu et al. CRITICAL REVIEWS IN IMMUNOLOGY
- Biotherapies targeting T and B cells: from immune suppression to immune tolerance
- (2015) Lucienne Chatenoud CURRENT OPINION IN PHARMACOLOGY
- PI3K inhibitors in inflammation, autoimmunity and cancer
- (2015) Anne-Katrien Stark et al. CURRENT OPINION IN PHARMACOLOGY
- Regulatory B Cells: Origin, Phenotype, and Function
- (2015) Elizabeth C. Rosser et al. IMMUNITY
- Nucleic acid-sensing TLRs and autoimmunity: novel insights from structural and cell biology
- (2015) Karin Pelka et al. IMMUNOLOGICAL REVIEWS
- Anti-CD20 Antibody Therapy and Susceptibility to Pneumocystis Pneumonia
- (2015) Waleed Elsegeiny et al. INFECTION AND IMMUNITY
- Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond
- (2015) Tobias Ruck et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity
- (2015) Jolien Suurmond et al. JOURNAL OF CLINICAL INVESTIGATION
- IgM and IgA Rheumatoid Factors Purified from Rheumatoid Arthritis Sera Boost the Fc Receptor– and Complement-Dependent Effector Functions of the Disease-Specific Anti–Citrullinated Protein Autoantibodies
- (2015) Florence Anquetil et al. JOURNAL OF IMMUNOLOGY
- Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus
- (2015) D C Salazar-Camarena et al. LUPUS
- Molecular Control of B Cell Activation and Immunological Synapse Formation
- (2015) Elina Kuokkanen et al. TRAFFIC
- CD19 as a molecular target in CNS autoimmunity
- (2014) Olaf Stüve et al. ACTA NEUROPATHOLOGICA
- Tofacitinib, a JAK inhibitor, inhibits human B cell activation in vitro
- (2014) Sheau-Pey Wang et al. ANNALS OF THE RHEUMATIC DISEASES
- TGF-β-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance
- (2014) Kang Mi Lee et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Bispecific T-cell engagers for cancer immunotherapy
- (2014) Amelia M Huehls et al. IMMUNOLOGY AND CELL BIOLOGY
- Live Cell Imaging Reveals that the Inhibitory Fc RIIB Destabilizes B Cell Receptor Membrane-Lipid Interactions and Blocks Immune Synapse Formation
- (2014) H. W. Sohn et al. JOURNAL OF IMMUNOLOGY
- Anti-CD79 Antibody Induces B Cell Anergy That Protects against Autoimmunity
- (2014) I. R. Hardy et al. JOURNAL OF IMMUNOLOGY
- Single Dose of Glycoengineered Anti-CD19 Antibody (MEDI551) Disrupts Experimental Autoimmune Encephalomyelitis by Inhibiting Pathogenic Adaptive Immune Responses in the Bone Marrow and Spinal Cord while Preserving Peripheral Regulatory Mechanisms
- (2014) Ding Chen et al. JOURNAL OF IMMUNOLOGY
- CD19 and CD32b Differentially Regulate Human B Cell Responsiveness
- (2014) J. L. Karnell et al. JOURNAL OF IMMUNOLOGY
- JAK inhibitor tofacitinib for treating rheumatoid arthritis: from basic to clinical
- (2014) Yoshiya Tanaka et al. Modern Rheumatology
- IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
- (2014) Ping Shen et al. NATURE
- Interleukin-35 induces regulatory B cells that suppress autoimmune disease
- (2014) Ren-Xi Wang et al. NATURE MEDICINE
- The BAFF/APRIL system in SLE pathogenesis
- (2014) Fabien B. Vincent et al. Nature Reviews Rheumatology
- PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
- (2014) Ajay K. Gopal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-CD22/CD20 Bispecific Antibody with Enhanced Trogocytosis for Treatment of Lupus
- (2014) Edmund A. Rossi et al. PLoS One
- Rheumatoid Factor as a Potentiator of Anti-Citrullinated Protein Antibody-Mediated Inflammation in Rheumatoid Arthritis
- (2014) Jeremy Sokolove et al. Arthritis & Rheumatology
- Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double-Blind, Phase III Study
- (2013) Eduardo F. Mysler et al. ARTHRITIS AND RHEUMATISM
- CD19 as a therapeutic target in a spontaneous autoimmune polyneuropathy
- (2013) P. M. Abraham et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Ibrutinib and novel BTK inhibitors in clinical development
- (2013) Akintunde Akinleye et al. Journal of Hematology & Oncology
- IL-21-Producing Th Cells in Immunity and Autoimmunity
- (2013) S. M. Liu et al. JOURNAL OF IMMUNOLOGY
- Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis
- (2013) Ulrich Specks et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
- (2013) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
- (2013) Xin Yao et al. PHARMACOLOGY & THERAPEUTICS
- B-cell targeted therapeutics in clinical development
- (2013) Stephan Blüml et al. ARTHRITIS RESEARCH & THERAPY
- Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis
- (2013) Meliha Crnkic Kapetanovic et al. ARTHRITIS RESEARCH & THERAPY
- IL-10-producing regulatory B cells (B10 cells) in autoimmune disease
- (2013) Ioannis Kalampokis et al. ARTHRITIS RESEARCH & THERAPY
- Suppression of Rheumatoid Arthritis B Cells by XmAb5871, an Anti-CD19 Antibody That Coengages B Cell Antigen Receptor Complex and Fcγ Receptor IIb Inhibitory Receptor
- (2013) Seung Y. Chu et al. Arthritis & Rheumatology
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- Somatic mutagenesis in autoimmunity
- (2012) Thiago Detanico et al. AUTOIMMUNITY
- Pneumocystis Pneumonia in Patients Treated With Rituximab
- (2012) Isabel Martin-Garrido et al. CHEST
- PD-1 is a novel regulator of human B-cell activation
- (2012) Marie-Laure Thibult et al. INTERNATIONAL IMMUNOLOGY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma
- (2011) P. A. Moore et al. BLOOD
- Recombinant human CD19-ligand protein as a potent anti-leukaemic agent
- (2011) Fatih M. Uckun et al. BRITISH JOURNAL OF HAEMATOLOGY
- Antibody-Mediated Coengagement of FcγRIIb and B Cell Receptor Complex Suppresses Humoral Immunity in Systemic Lupus Erythematosus
- (2011) Holly M. Horton et al. JOURNAL OF IMMUNOLOGY
- Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
- (2011) Kamran Ghoreschi et al. JOURNAL OF IMMUNOLOGY
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
- (2011) Ludwig Kappos et al. LANCET
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study
- (2010) Gabor G. Illei et al. ARTHRITIS AND RHEUMATISM
- IL-6 increases B-cell IgG production in a feed-forward proinflammatory mechanism to skew hematopoiesis and elevate myeloid production
- (2010) K. Maeda et al. BLOOD
- B-cell targeted therapies in human autoimmune diseases: an updated perspective
- (2010) Michael J. Townsend et al. IMMUNOLOGICAL REVIEWS
- B-Cell Depletion In Vitro and In Vivo with an Afucosylated Anti-CD19 Antibody
- (2010) R. Herbst et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
- (2010) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo
- (2009) Roland Axmann et al. ARTHRITIS AND RHEUMATISM
- A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus
- (2009) Daniel J. Wallace et al. ARTHRITIS AND RHEUMATISM
- Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial
- (2009) Clifton O. Bingham et al. ARTHRITIS AND RHEUMATISM
- Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab
- (2009) Sander van Assen et al. ARTHRITIS AND RHEUMATISM
- The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells In vitro and In vivo
- (2009) H. Ikeda et al. CLINICAL CANCER RESEARCH
- The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+T cells
- (2009) Oliver Dienz et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-21: An Executor of B Cell Fate
- (2009) D. Konforte et al. JOURNAL OF IMMUNOLOGY
- CD40 and autoimmunity: The dark side of a great activator
- (2009) Anna L. Peters et al. SEMINARS IN IMMUNOLOGY
- Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis
- (2009) Maria Rehnberg et al. ARTHRITIS RESEARCH & THERAPY
- Review: Natalizumab in the treatment of multiple sclerosis
- (2009) Özgür Yaldizli et al. Therapeutic Advances in Neurological Disorders
- The effects of IL-6 on CD4 T cell responses
- (2008) Oliver Dienz et al. CLINICAL IMMUNOLOGY
- B-cell tolerance checkpoints in health and autoimmunity
- (2008) Eric Meffre et al. CURRENT OPINION IN IMMUNOLOGY
- A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
- (2008) Koichi Yanaba et al. IMMUNITY
- The effects of natalizumab on the innate and adaptive immune system in the central nervous system
- (2008) Olaf Stüve JOURNAL OF THE NEUROLOGICAL SCIENCES
- Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcγRIIb with Fc-engineered antibodies
- (2008) Seung Y. Chu et al. MOLECULAR IMMUNOLOGY
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- The inhibitory collagen receptor LAIR-1 (CD305)
- (2007) L. Meyaard JOURNAL OF LEUKOCYTE BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now